During the past decade, Burswood Dermatology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Burswood Dermatology" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Burswood Dermatology" are "Atopic Dermatitis" (4 trials), "Acne Vulgaris" (1 trials), "Actinic Keratoses" (1 trials), "Actinic Keratosis" (1 trials) and "Superficial Basal Cell Carcinoma" (1 trials). Many other conditions were trialed in "Burswood Dermatology" in a lesser frequency.

Most popular intervention types in "Burswood Dermatology" are "Drug" (5 trials), "Biological" (3 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (3 trials), "Placebo" (2 trials), "Aluminium disk" (1 trials), "Ingenol mebutate gel 0.05%" (1 trials) and "Olumacostat Glasaretil Gel, 5.0%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Burswood Dermatology" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Burswood Dermatology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Burswood Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Burswood Dermatology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".